News

intelerad
Radiology world reacts to GE HealthCare’s blockbuster $2B deal to buy Intelerad

Chicago imaging systems manufacturer GEHC said Nov. 20 it hopes to close the transaction by the first half of 2026, subject to regulatory approvals and other conditions. 

Nvidia
Nvidia CEO discusses AI’s growing prevalence in radiology

Jensen Huang spoke alongside Elon Musk Nov. 19 at the U.S.-Saudi business forum held in Washington, D.C. 

statue justice legal verdict malpractice case lawsuit scale
Judge rules hospital isn’t liable for discarded brain of gene therapy patient

Children's Wisconsin admitted that it accidentally threw out the brain of a 24-year-old woman who survived a rare childhood illness as a result of a novel gene therapy. A researcher called the organ “irreplaceable.” 

the words "FDA recall" on a board
FDA issues recall on video laryngoscopes after battery leaks, power failures

A model of i-View Video Laryngoscopes manufactured by Intersurgical is defective and will need to be removed from patient care settings and supply houses immediately, as they pose a serious risk to patient health.

business partnership handshake merger acquisition M&A
Abbott acquires cancer diagnostic company Exact Sciences for $21B

The deal will not be finalized until approved by Exact Sciences’ shareholders. With it, Abbott gains control of new diagnostic tools, including a popular at-home test for colorectal cancer.

Thumbnail
Washington hospital open since 1887 pauses heart transplant program due to vacancies

No other heart or transplant services at the nonprofit hospital should be impacted by this temporary shift in care. 

Boston Scientific partners with Epic on data integration

The collaboration allows providers to order diagnostic tests and then receive results directly in Epic.

Semaglutide, other obesity drugs show potential to treat nondiabetic stroke

Much more research is still required, but a new meta-analysis in Stroke suggests these medications may provide valuable stroke prevention.

The new cardiac PET radiotracer flurpiridaz F-18 is posed to be a major game changer and will likely lead to increased adoption of cardiac PET.
‘A significant milestone’: First US patients receive doses of new PET radiotracer for CAD

Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care. 

Prevail DCB Medtronic
Medtronic enrolls first patient in new coronary DCB trial—data could lead to FDA approval

The paclitaxel-coated device, already approved in Europe and other parts of the world, will be tested on more than 1,200 patients for a new international trial. If the study is a success, Medtronic hopes to gain regulatory approval in the United States and Japan. 

Radiology Partners
Radiology Partners fires back in battle with Aetna, accusing payer of ‘shamelessly prioritizing profits’

"We vehemently refute all their manufactured allegations, and we will vigorously defend our position," CEO Rich Whitney, MBA, said Wednesday. 

Compremium has developed a noninvasive external assessment that does away with needles for the diagnosis of venous pressure conditions using AI-enabled monitoring.
Healthcare AI newsmakers: Chief AI & transformation officers, AI Rorschach testers, citizens united for responsible healthcare AI, more

Less alarm fatigue in overworked pediatric nurses means more time for imperiled pediatric patients. 

Around the web

Radiology Business
Radiology world reacts to GE HealthCare’s blockbuster $2B deal to buy Intelerad

Chicago imaging systems manufacturer GEHC said Nov. 20 it hopes to close the transaction by the first half of 2026, subject to regulatory approvals and other conditions. 

Radiology Business
Nvidia CEO discusses AI’s growing prevalence in radiology

Jensen Huang spoke alongside Elon Musk Nov. 19 at the U.S.-Saudi business forum held in Washington, D.C. 

Health Exec
Judge rules hospital isn’t liable for discarded brain of gene therapy patient

Children's Wisconsin admitted that it accidentally threw out the brain of a 24-year-old woman who survived a rare childhood illness as a result of a novel gene therapy. A researcher called the organ “irreplaceable.” 

Design by Adaptive Theme